Double-hit Lymphoma (DHL)
1 clinical trials · Condition
◉ Watch Double-hit Lymphoma (DHL)
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma (NCT01742988) | Curis, Inc. | 2012-12-01 |
Track Double-hit Lymphoma (DHL) automatically
Every clearance here is in the API, with alerts when new ones post.